학술논문
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
Document Type
Article
Author
Source
In: Gynecologic Oncology . (Gynecologic Oncology, March 2023, 170:241-247)
Subject
Language
English
ISSN
10956859
00908258
00908258